Sexual dimorphism in the osteoarthritis of STR/ort mice may be linked to articular cytokines

Annals of the Rheumatic Diseases

Volumn 62, Issue 12, 2003, Pages 1234-1237

  Mahr, S ^a   Menard, J ^a   Krenn, V ^b   Muller B ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EOSIN; HEMATOXYLIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CARTILAGE DEGENERATION; CIRCULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; IMMUNOHISTOCHEMISTRY; JOINT DEGENERATION; KNEE; MALE; MOUSE STRAIN; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; SEX DIFFERENCE; STAINING;

ANIMALS; CARTILAGE, ARTICULAR; CHONDROCYTES; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED STRAINS; OSTEOARTHRITIS, KNEE; SEX CHARACTERISTICS;

EID: 0344197013     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2002.005041     Document Type: Article

References (14)

1. Westacott CI, Sharif M. Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 1996;25:254-72.
2. Lafeber FP, Vander Kraan PM, Huber-Bruning O, Vanden Berg WB, Bijlsma JW. Osteoarthritic human cartilage is more sensitive to transforming growth factor beta than is normal cartilage. Br J Rheumatol 1993;32:281-6.
3. van den Berg WB. Joint inflammation and cartilage destruction may occur uncoupled. Springer Semin Immunopathol 1998;20:149-64.
4. van Roon JA, van Roy JL, Gmelig Meyling FH, Lafeber FP, Bijlsma JW. Prevention and reversal af cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
5. Moos V, FickertS, Müller B, Weber U, Sieper J. Immunohistochemical analysis of cytokine expression in human osteoorthritic and healthy cartilage. J Rheumatol 1999;26:870-9.
6. Walton M. Degenerative joint disease in the mouse knee: histological observations. J Pathol 1977;123:109-22.
7. Mason RM, Chambers MG, Flannelly J, Gaffen JD, Dudhia J, Bayliss MT. The STR/ort mouse and its use as a model of osteoarthritis. Osteoarthritis Cartilage 2001;9:85-91.
8. Felson DT, Nevitt MC. The effects of estrogen on osteoarthritis. Curr Opin Rheumatol 1998;10:269-72.
9. Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Sveinbjornsson B. Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 2001;287:190-7.
10. Müller B. Cytokine imbalance in non-immunological chronic disease. Cytokine 2002;18:334-9.
11. Moos V, Sieper J, Herzog V, Müller B. Regulation of expression of cytokines and growth factors in osteoarthritic cartilage explants. Clin Rheumatol 2001;20:353-8.
12. Wluka AE, Davis SR, Bailey M, Stuckey SL, Cicuttini FM. Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann Rheum Dis 2001;60:332-6.
13. Chambers MG, Suri N, Cover P, Buckingham J, Visco D, Mason RM. Aggrecan degradation and osteoarthritis in STR/ort mice occur independently or sex and sex hormone status. 45th Annual Meeting, Orthopedic Society. Anaheim, CA, 1999:447.
14. Chambers MG, Bayliss MT, Mason RM. Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 1997;5:301-8.